India Precision Oncology Market Size & Outlook, 2024-2030
India precision oncology market, 2018-2030 (US$M)
Related Markets
India precision oncology market highlights
- The India precision oncology market generated a revenue of USD 4,363.5 million in 2024 and is expected to reach USD 8,900.9 million by 2030.
- The India market is expected to grow at a CAGR of 12.6% from 2025 to 2030.
- In terms of segment, therapeutics was the largest revenue generating product in 2024.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Precision oncology market data book summary
| Market revenue in 2024 | USD 4,363.5 million |
| Market revenue in 2030 | USD 8,900.9 million |
| Growth rate | 12.6% (CAGR from 2025 to 2030) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Thermo Fisher Scientific Inc, Invitae Corp, Qiagen NV, Illumina Inc, Exact Sciences Corp, Rain Oncology, Strata Oncology, Xilis, Variantyx, BioServe, Relay Therapeutics, Acrivon Therapeutics |
Other key industry trends
- In terms of revenue, India accounted for 3.8% of the global precision oncology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan precision oncology market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,900.9 million by 2030.
Therapeutics was the largest segment with a revenue share of 79.94% in 2024. Horizon Databook has segmented the India precision oncology market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The India precision oncology market is projected to grow at the fastest CAGR throughout the forecast period. The development of accessible and affordable innovative therapies in the country is exemplified by the launch of India’s first home-grown CAR-T cell therapy for cancer. This breakthrough gene therapy, launched in April 2024, is a significant advancement in cancer treatment, offering a promising option for patients who previously lacked access to such therapies due to high costs.
As CAR-T cell therapy becomes more affordable, it increases access to cutting-edge treatments, helping to address cancer in the Indian population. This initiative not only demonstrates the country's growing capabilities in biotechnology but also aligns with the broader movements, further driving the market growth in India.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Precision Oncology Market Scope
Precision Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India precision oncology market size, by product, 2018-2030 (US$M)
India Precision Oncology Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
